Cargando…
Risk of mortality associated with concomitant antidepressant and benzodiazepine therapy among patients with depression: a population-based cohort study
BACKGROUND: With antidepressants (ADs) having minimal therapeutic effects during the initial weeks of treatment, benzodiazepines (BZDs) are concomitantly used to alleviate depressive symptoms of insomnia or anxiety. However, with mortality risks associated with this concomitant use yet to be examine...
Autores principales: | Jeong, Han Eol, Jeon, Ha-Lim, Oh, In-Sun, Kim, Woo Jung, Shin, Ju-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724883/ https://www.ncbi.nlm.nih.gov/pubmed/33292197 http://dx.doi.org/10.1186/s12916-020-01854-w |
Ejemplares similares
-
The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication
por: Andrashko, Veronika, et al.
Publicado: (2020) -
Pattern evolution of antidepressants and benzodiazepines use in a cohort
por: Alcantara, Geisy de Carvalho, et al.
Publicado: (2020) -
Efficacy of antidepressants and benzodiazepines in minor
depression: systematic review and meta-analysis
por: Barbui, Corrado, et al.
Publicado: (2011) -
Effects of Concomitant Benzodiazepines and Antidepressants Long-Term Use on Social Decision-Making: Results From the Ultimatum Game
por: Fernandes, Carina, et al.
Publicado: (2022) -
Antidepressant Activities of Synthesized Benzodiazepine Analogues in Mice
por: Haq, Faizan Ul, et al.
Publicado: (2023)